Literature DB >> 21402899

IFN-α mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms.

Nagako Akeno1, Eric P Smith, Mihaela Stefan, Amanda K Huber, Weijia Zhang, Mehdi Keddache, Yaron Tomer.   

Abstract

IFN-α is known to play a key role in autoimmunity, but the mechanisms are uncertain. Although the induction of autoimmunity by IFN-α is consistent with primarily immunomodulatory effects, the high frequency of nonautoimmune inflammation suggests other mechanisms. We used thyroiditis as a model to dissect these possibilities. IFN-α treatment of cultured thyrocytes increased expression of thyroid differentiation markers, thyroglobulin, thyroid-stimulating hormone receptor, thyroid peroxidase, and sodium iodide transporter. RNAseq analysis demonstrated that pathways of Ag presentation, pattern recognition receptors, and cytokines/chemokines were also stimulated. These changes were associated with markedly increased nonapoptotic thyroid cell death, suggesting direct toxicity. To corroborate these in vitro findings, we created transgenic mice with thyroid-specific overexpression of IFN-α under control of the thyroglobulin promoter. Transgenic mice developed marked inflammatory thyroid destruction associated with immune cell infiltration of thyroid and surrounding tissues leading to profound hypothyroidism, findings consistent with our in vitro results. In addition, transgenic mice thyroids showed upregulation of pathways similar to those observed in cultured thyrocytes. In particular, expression of granzyme B, CXCL10, a subset of the tripartite motif-containing family, and other genes involved in recruitment of bystander cytotoxic immune responses were increased. Pathways associated with apoptosis and autophagy were not induced. Taken together, our data demonstrate that the induction of tissue inflammation and autoimmunity by IFN-α involves direct tissue toxic effects as well as provocation of destructive bystander immune responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402899      PMCID: PMC3106338          DOI: 10.4049/jimmunol.1002631

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

Review 1.  Type I interferons and T helper development.

Authors:  J D Farrar; K M Murphy
Journal:  Immunol Today       Date:  2000-10

Review 2.  Perforin-mediated target-cell death and immune homeostasis.

Authors:  Ilia Voskoboinik; Mark J Smyth; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2006-12       Impact factor: 53.106

Review 3.  Type I interferon receptors: biochemistry and biological functions.

Authors:  Nicole A de Weerd; Shamith A Samarajiwa; Paul J Hertzog
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

4.  Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone.

Authors:  J Pohlenz; A Maqueem; K Cua; R E Weiss; J Van Sande; S Refetoff
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

Review 5.  Cell death by necrosis: towards a molecular definition.

Authors:  Pierre Golstein; Guido Kroemer
Journal:  Trends Biochem Sci       Date:  2006-12-01       Impact factor: 13.807

6.  Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.

Authors:  Tatjana Marinkovic; Alexandre Garin; Yoshifumi Yokota; Yang-Xin Fu; Nancy H Ruddle; Glaucia C Furtado; Sergio A Lira
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

7.  Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid.

Authors:  P Caturegli; M Hejazi; K Suzuki; O Dohan; N Carrasco; L D Kohn; N R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.

Authors:  Mario Rotondi; Roberta Minelli; Flavia Magri; Paola Leporati; Paola Romagnani; Maria Cristina Baroni; Roberto Delsignore; Mario Serio; Luca Chiovato
Journal:  Eur J Endocrinol       Date:  2007-04       Impact factor: 6.664

9.  Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells.

Authors:  Satish Devadas; Jyoti Das; Catherine Liu; Liying Zhang; Arthur I Roberts; Zui Pan; Paul A Moore; Gobardhan Das; Yufang Shi
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

Review 10.  Potential therapeutic applications of autophagy.

Authors:  David C Rubinsztein; Jason E Gestwicki; Leon O Murphy; Daniel J Klionsky
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694

View more
  27 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism.

Authors:  Mihaela Stefan; Eric M Jacobson; Amanda K Huber; David A Greenberg; Cheuk Wun Li; Luce Skrabanek; Erlinda Conception; Mohammed Fadlalla; Kenneth Ho; Yaron Tomer
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

Review 3.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

4.  Interferon-α Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin.

Authors:  Larissa C Faustino; Angela Lombardi; Julio Madrigal-Matute; Randall P Owen; Steven K Libutti; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

5.  Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity.

Authors:  Mihaela Stefan; Chengguo Wei; Angela Lombardi; Cheuk Wun Li; Erlinda S Concepcion; William B Inabnet; Randall Owen; Weijia Zhang; Yaron Tomer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-13       Impact factor: 11.205

Review 6.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

7.  Hepatitis C Virus E2 Protein Induces Upregulation of IL-8 Pathways and Production of Heat Shock Proteins in Human Thyroid Cells.

Authors:  Sara Salehi Hammerstad; Mihaela Stefan; Jason Blackard; Randall P Owen; Hanna J Lee; Erlinda Concepcion; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

Review 8.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

9.  Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.

Authors:  Alia Hasham; Weijia Zhang; Vaneet Lotay; Shannon Haggerty; Mihaela Stefan; Erlinda Concepcion; Douglas T Dieterich; Yaron Tomer
Journal:  J Autoimmun       Date:  2013-05-15       Impact factor: 7.094

10.  Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.

Authors:  Sara Salehi Hammerstad; Jason T Blackard; Angela Lombardi; Randall P Owen; Erlinda Concepcion; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.